Products for Research Use Only
RegisterLogin

DOTA-Pep-1L

CAT: 0804-HY-P11287Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P11287Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DOTA-Pep-1L is a peptide conjugated with DOTA and Pep-1L, a peptide that specifically targets the IL13RA2 receptor. DOTA-Pep-1L can be used for PET imaging and tumor-targeted therapy research[1].
UNSPSC
12352100
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
O=C(N[C@@H](CS)C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CCSC)C(NCC(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CS)C(NCC(NCC(NCC(N[C@@H](CO)C(NCCCCCC(N[C@@H](CCCCN)C(N[C@@H](CCCCNC(CN3CCN(CCN(CCN(CC3)CC(O)=O)CC(O)=O)CC(O)=O)=O)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
Molecular Formula
C88H146N28O27S3
Molecular Weight
2124.47
References & Citations
[1]Sattiraju A, et al. IL13RA2 targeted alpha particle therapy against glioblastomas. Oncotarget. 2017 Jun 27;8 (26) :42997-43007.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P10292NOTA-Pep-1L
HY-163040DOTA-Tyr-Lys-DOTA
HY-P11254DOTA-FAPT
HY-163039DOTA-biotin
HY-139564DOTA Zoledronate
HY-W802013DOTA-4AMP
HY-W038001DOTA-benzene
HY-P5128-01DOTA-JR11
HY-133540-01Maleimide-DOTA
HY-W678394-01DOTA-Thiol

Alternative Products

CatalogName
TP3927-01DOTA-Pep-1L
GTR19144673-01DOTA-Pep-1L TFA
TP3556-01NOTA-Pep-1L
GTR19267069-01DOTA-Tyr-Lys-DOTA
TRC-D535500-250MGDOTA
PB0687PEP-TRI (PEP-3CHA)
BA5818-1DOTA-LM3
413907Gd-DOTA
4029066.0250DOTA (OtBu) ₃
4029066.05DOTA(OtBu)₃

Popular Products